Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Joseph Loscalzo
AddedMar 31, 2024
UpdatedMay 31, 2026
Joseph Loscalzo

Joseph Loscalzo

Board Member, Ionis Pharmaceuticals

Crunchbase

Joseph Loscalzo's Career

Ionis Pharmaceuticals
Ionis Pharmaceuticals

Carlsbad, CA, US

Board Member· Board
Targanox
Targanox

Boston, MA, US

Board Member· Board
Scipher Medicine
Scipher Medicine

Waltham, MA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Joseph Loscalzo's Career

Ionis Pharmaceuticals
Ionis Pharmaceuticals
Public$1.3B7961989Carlsbad, CA, US
Board Member· Board

Leadership at Ionis Pharmaceuticals

Chris MirabelliChris MirabelliFounder
B. Lynne ParshallB. Lynne ParshallBoard Member
Brett P. MoniaBrett P. MoniaBoard Member
Stanley CrookeStanley CrookeBoard Member
Spencer BerthelsenSpencer BerthelsenBoard Member
joseph wenderjoseph wenderBoard Member
Targanox
Targanox
$5.1M82008Boston, MA, US
Board Member· Board

Leadership at Targanox

Roger KittermanRoger KittermanBoard Member
Geoffrey SmithGeoffrey SmithBoard Member
Avi KometzAvi KometzCEO
Gordon LettsGordon LettsCo-Founder
Kate CarrollKate CarrollCo-Founder

Similar to Targanox

NovatargNovatargDurham, NC, USPharmaceuticalsest. 2009NovatargDurham, NC, US · est. 2009

NovaTarg Therapeutics: A private pharma firm specializing in tissue-targeted drug discovery.

Seed · $3.2M5
AgentixAgentixDana Point, CA, USBiopharmaceuticalsest. 2013AgentixDana Point, CA, US · est. 2013

Agentix, a biopharmaceutical firm, develops health solutions and modulates the ECS for therapeutic targets, based in California.

Public · $808.3k7
KinDex PharmaceuticalsKinDex PharmaceuticalsSeattle, WA, USTherapeuticsest. 2009KinDex PharmaceuticalsSeattle, WA, US · est. 2009

KinDex Pharmaceuticals develops novel therapeutics for metabolic disorder treatment.

Angel · $5.8M10
Tigris PharmaceuticalsTigris PharmaceuticalsBonita Springs, FL, USCancer Treatmentsest. 2005Tigris PharmaceuticalsBonita Springs, FL, US · est. 2005

Tigris Pharmaceuticals: Innovating biopharmaceutical solutions for cancer and other medical needs.

Series C · $32.5M6
Scipher Medicine
Scipher Medicine
Series D$227M1342015Waltham, MA, US
Co-Founder

Leadership at Scipher Medicine

Albert-Laszlo BarabasiAlbert-Laszlo BarabasiCo-Founder
Alif SalehAlif SalehCEO

Similar to Scipher Medicine

MedecipherMedecipherDenver, CO, USDecision Supportest. 2017MedecipherDenver, CO, US · est. 2017

Medecipher provides real-time, predictive analytics-based decision support tools to optimize hospital operations.

Pre-Seed · $1.3M12
CipheromeCipheromeSan Jose, CA, USDrug Discoveryest. 2016CipheromeSan Jose, CA, US · est. 2016

Cipherome: A biotech firm specializing in personalized drug discovery to optimize individual health.

Series B · $19.5M26
Endpoint HealthEndpoint HealthPalo Alto, CA, USTests, Therapeuticsest. 2018Endpoint HealthPalo Alto, CA, US · est. 2018

Endpoint Health: Personalized therapies for immune-driven illnesses, improving patient outcomes.

$64.2M
Celsius TherapeuticsCelsius TherapeuticsCambridge, MA, USTherapeuticsest. 2018Celsius TherapeuticsCambridge, MA, US · est. 2018

Celsius Therapeutics, a US-based biotech firm, develops drugs for cancer and autoimmune diseases.

Series B · $148M72

People Similar to Joseph Loscalzo

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMitchell GoldMitchell GoldCo-Founder & CEO · Alpine Immune SciencesScott RocklageScott RocklageBoard Member · WaveRxJoe Cook JrJoe Cook JrFounder · Device Innovation GroupChristopher M. CashmanChristopher M. CashmanBoard Member · University City Science CenterDavid PerryDavid PerryCo-Founder · NexpriseMartin EdwardsMartin EdwardsBoard Member · KalVista Pharmaceuticals